Having trouble accessing articles? Reset your cache.

AGS-004: Updated Phase IIa data

Updated data from the ongoing, open-label, Canadian Phase IIa CTN 239 trial in 22 patients who completed a 12-week structured antiretroviral therapy (ART)

Read the full 232 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE